Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
Antisense and Sensibility in RNA Therapeutics
RNAi may be the media darling, but other mRNA-targeting tools are making strides
Email: Laura Lane - llane@the-scientist.com The Scientist 2005, 19(1):30
|
||||
|
|
||||
|
These days RNA interference seems to be everywhere. A bonafide hit in research labs worldwide, the sequence-specific gene-silencing approach is now making inroads in drug-development circles. But RNAi is not the first targeted nucleic acid-based approach to garner both accolades and pharmaceutical dollars.
|
|
|||||||||
|
|||||||||
|
